Plasma levels ofd-Dimer: a crosslinked fibrin-degradation product in female breast cancer
Authors:
- 1 May 1991
- journal article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 117 (3) , 259-262
Abstract
Plasma levels ofd-dimer, a degradation product of crosslinked fibrin, were determined in 73 patients with breast cancer. In these patients, significantly elevated plasma levels ofd-dimer were found, as compared to healthy controls (Pr=0.40;Pr=0.39;PPr= 0.25;P<0.05) was found. We conclude that the increase in plasmad-dimer and TAT levels might reflect an enhanced activation of the clotting system in patients with breast cancer.Keywords
This publication has 22 references indexed in Scilit:
- Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction.Circulation, 1987
- Tissue plasminogen activators in breast cancerThrombosis Research, 1987
- Elevated serum D dimer: A degradation product of cross-linked fibrin (XDP) after intravenous streptokinase during acute myocardial infarctionJACC, 1986
- Hemostatic alterations are unrelated to the stage of tumor in untreated malignant melanoma and breast carcinomaEuropean Journal of Cancer and Clinical Oncology, 1985
- A simple chromatographic procedure for the purification of the D dimer fragment from crosslinked fibrinAnalytical Biochemistry, 1985
- Measurement of cross linked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies.Journal of Clinical Pathology, 1984
- Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast TumorsHybridoma, 1984
- An immunoassay for human D dimer using monoclonal antibodiesThrombosis Research, 1983
- Distinction between fibrinogen and fibrin degradation products in plasmaClinica Chimica Acta, 1975